InceptionR’s Disc Medicine IRON Stock Holding History

InceptionR’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,489	Closed	-$415K	–	778
2026 Q1	$415K	Buy	+6,489	New	+$450K	0.1%	375

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

InceptionR's IRON Position: Q2 2026 in Review

InceptionR sold out of Disc Medicine (IRON) in Q2 2026, closing a stake of 6,489 shares — an estimated $415K sold.

InceptionR first reported a position in IRON in Q1 2026 and held it in 1 quarter. The position peaked at $415K in Q1 2026. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

InceptionR reported no remaining Disc Medicine position as of Q2 2026 after selling out during the quarter.
InceptionR sold 6,489 Disc Medicine shares in Q2 2026, an estimated $415K.
InceptionR first reported a position in Disc Medicine in Q1 2026 and held it in 1 quarter.
InceptionR's Disc Medicine position peaked at $415K in Q1 2026.
216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.